Sequence information
Variant position: 148 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 337 The length of the canonical sequence.
Location on the sequence:
IHQFVECLKLNKKPFHLVGT
S MGGQVAGVYAAYYPSDVSSL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human IHQFVECLKLNKKPFHLVGTS MGGQVAGVYAAYYPSDVSSL
Mouse IHQFVECLKLNKKPFHLIGTS MGGHVAGVYAAYYPSDVCSL
Rat IHQFVECLKLNKKPFHLIGTS MGGNVAGVYAAYYPSDVCSL
Bovine IHQFVECLKLNKKPFHLVGTS MGGHVAGVYAAHYPSDVCSL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 337
Monoacylglycerol lipase ABHD6
Topological domain
30 – 337
Cytoplasmic
Domain
72 – 313
AB hydrolase-1
Active site
148 – 148
Nucleophile
Mutagenesis
148 – 148
S -> A. Loss of 2-arachidonoyglycerol hydrolase activity.
Literature citations
alpha/beta hydrolase domain-containing 6 (ABHD6) degrades the late endosomal/lysosomal lipid bis(monoacylglycero)phosphate.
Pribasnig M.A.; Mrak I.; Grabner G.F.; Taschler U.; Knittelfelder O.; Scherz B.; Eichmann T.O.; Heier C.; Grumet L.; Kowaliuk J.; Romauch M.; Holler S.; Anderl F.; Wolinski H.; Lass A.; Breinbauer R.; Marsche G.; Brown J.M.; Zimmermann R.;
J. Biol. Chem. 290:29869-29881(2015)
Cited for: FUNCTION; CATALYTIC ACTIVITY; VARIANTS HIS-113; CYS-148; LEU-204; PRO-206 AND VAL-231; CHARACTERIZATION OF VARIANTS HIS-113; CYS-148; LEU-204; PRO-206 AND VAL-231;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.